MTRG-banner

MTRG Past Projects

Find out more about projects completed by the Medical Technology Research Group

We provide high quality consulting services to pharmaceutical companies and other organisations, collaborating with Market Access, HTA, Pricing, Policy and Government Affairs teams

Dr Jennifer Gill, Associate Director, MTRG

The-Promise-of-Population-Health-Management-in-England

Population Health Management in England
October 2022
Client: Novartis 

Find out more here. 


Towards-better-outcomes-in-autism-by-addressing-policy-change

Outcomes in Autism
October 2022
Client: F. Hoffmann La Roche

Find out more here.


Access-to-medicines-in-Europe

Access to Medicines in Europe
November 2021
Client: MSD

Find out more here. 


The-Role-of-Virtual-Health-Care-and-the-Pharmaceutical-Sector-in-Improving-Population-Health

Population Health and Virtual Care
June 2021
Client: Sanofi 

Find out more here. 


PhRMA-Headroom-Front-Cover

Headroom for Innovation in Egypt and the Kingdom of Saudi Arabia
May 2021
Client: PhRMA

Find out more here. 


Severe-Asthma

Severe Asthma
May 2021
Client: AstraZeneca

Find out more here. 


Predictive-Analytic-Techniques

Predictive Analytic Tools and Value-Based Healthcare
February 2021
Client: Takeda

Find out more here. 


Indication-Based-Pricing-of-Innovative-Medicines

Indication-Based Pricing of Innovative Medicines
October 2020
Client: Novartis 

Find out more here. 


Personalised-Oncology-in-Europe

Access to Personalised Oncology in Europe 
November 2020 
Client: EFPIA

Find out more here. 


Financing-High-Cost-Curative-Therapies

Financing High-Cost Curative Therapies
October 2020
Client: Novartis

Find out more here. 


Latin-America-Healthcare-System-Overview

Latin American Health System Overview
August 2019
Client: F. Hoffmann La Roche

Find out more here. 


Pharmaceutical-Policy-in-China

Pharmaceutical Policy in China
May 2019
Client: Gilead Sciences

Find out more here. 


The-use-of-Real-World-Evidence-–-Opportunities-for-Europe

The Use of Real World Evidence
November 2016 - December 2019
Client: F. Hoffmann La Roche

Find out more here. 

 


Pharmaceutical-Pricing-and-Reimbursement-in-the-Middle-East

Pharmaceutical Pricing and Reimbursement in the Middle East and North Africa Region
November 2018
Client: PhRMA

Find out more here. 


Changing-paradigms-in-the-management-of-Multiple-Sclerosis

Changing paradigms in the management of Multiple Sclerosis
November 2018
Client: F. Hoffmann La Roche

Find out more here. 


Accelerated-Approval-and-Access-Schemes

Accelerated Approval and Access Schemes - New Oncology Medicines
May 2017 – November 2019
Client: AstraZeneca

Find out more here. 


European-survey-on-the-use-of-Real-World-Evidence

European survey on the use of Real World Evidence
January 2017 - May 2018
Client: F. Hoffmann La Roche

Find out more here. 


External-Reference-Pricing-within-and-across-countries

External Reference Pricing
January 2016 - November 2017
Client: Pfizer

Find out more here. 


Improving-Outcomes-for-People-with-MS

Improving Outcomes for People with Multiple Sclerosis
October 2017
Client: F. Hoffmann La Roche

Find out more here. 


Improving-Access-to-Contraception

Improving Access to Contraception
September 2017 
Client: Pfizer

Find out more here. 


Study-on-impact-analysis-of-policy-options-for-strengthening-EU-cooperation-on-Health-Technology-Assessment-HTA

Policy Options for strengthened EU cooperation on Health Technology Assessment (HTA)
August 2017
Client: European Commission

Find out more here. 

Check back later for our latest Twitter updates.

Contact us

Address

LSE Health, Cowdray House, London School of Economics and Political Science, Houghton Street, London WC2A 2AE

Follow us

LinkedIn Twiiter